Summary (tl;dr)

Over 2.5 million bottles of prescription prednisolone acetate ophthalmic suspension eye drops have been voluntarily recalled nationwide due to the presence of a foreign substance, prompting a Class II recall by the Food and Drug Administration (FDA).

Essential Background

Prednisolone Acetate Ophthalmic Suspension, USP 1%, is a commonly prescribed steroid eye drop. It is used to alleviate redness, itchiness, swelling, and inflammation in the eyes, which can stem from infections or other conditions. This particular generic formulation received FDA approval in August 2024.

The Full Story

More than 2.5 million bottles of Prednisolone Acetate Ophthalmic Suspension eye drops, manufactured by Lupin Limited, are currently under a voluntary nationwide recall. The recall was initially announced in early June and was subsequently classified as a Class II recall by the FDA in late June. The primary reason for this action is the discovery of a "foreign substance" within the product. The recall encompasses 5 mL, 10 mL, and 15 mL bottles, covering numerous lot numbers with expiration dates ranging from July 2026 to March 2028. Distributors, such as Hilco Vision, have already advised their customers, including eyecare providers, to immediately cease using and quarantine any affected products.

Why It Matters

A Class II recall indicates that exposure to the affected product could lead to temporary or medically reversible adverse health consequences, or that the likelihood of serious adverse health consequences is remote. Potential health risks associated with the foreign substance in the eye drops include inflammatory responses, mechanical irritation, corneal injury, and secondary ocular inflammation. Patients who are using Prednisolone Acetate Ophthalmic Suspension are urged to verify their product's National Drug Code (NDC), lot number, and expiration date against the recall information, and to consult their healthcare provider for guidance if their medication is affected. This event underscores the critical importance of stringent quality control in pharmaceutical manufacturing and regulatory oversight to safeguard patient health.

Geographic Location

• Pithampur, Madhya Pradesh, India (manufacturing location of recalled eye drops)
• United States (nationwide distribution of recalled eye drops, FDA recall classification)